finance / Stocks & ETFs

Nuvalent, Inc. (NUVL): Investment Memo

Nuvalent (NASDAQ: NUVL) is a clinical-stage biotechnology company developing next-generation targeted cancer therapies. Learn about its oncology pipeline, growth drivers, risks, GSK acquisition, and long-term investment potential.